Indian Immunologicals Limited
- Hyderabad
Hyderabad’s IIL develops needle-free intranasal COVID-19 vaccine
Hyderabad: Indian Immunologicals Limited (IIL), a vaccine maker based in Hyderabad, has developed a live-attenuated, needle-free intranasal booster vaccine against SARS-CoV-2 in collaboration with Griffith University, Australia. The vaccine, named CDO-7N-1, was…
- Hyderabad
Hyderabad: IIL to invest Rs 700 cr for new animal vaccine facility
Hyderabad: Indian Immunologicals Limited (IIL) has announced it will open the “Vaccine Hub of the World” at a cost of Rs 700 crores here on Monday. Vaccination will be provided against economically important…
